y Middlesex Sciences, of Foxborough, Mass., has named Thomas J.Facklam vice president of research and development.y Pharmagenesis Inc., of Palo Alto, Calif., has named Robert Tidwellvice president and general manager of the Pharmagenesis U.S.operation.y Ribogene Inc., of Hayward, Calif., has appointed Thomas Prestonvice president, business development; Vincent Miles vice president,research; and Susan Simmons, director of finance and controller.y Oncogene Science Inc., of Uniondale, N.Y., has named Ann Rosecorporate vice president.y Cambridge Neuroscience Inc., of Cambridge, Mass., has appointedGilbert Block vice president, clinical development.y Human Genome Sciences, of Rockville, Md., has appointed MichaelFannon director of bioinformatics.y Genetics Institute Inc., of Cambridge, Mass., has appointed ThomasDesRosier vice president and chief patent counsel.y Robertson, Stephens and Co., of San Francisco, has appointedEdward Hurwitz a vice president and senior research analyst inbiotechnology.y GeneMedicine Inc., of Houston, has appointed Kathryn Stankis vicepresident, administration and human resources.y CytRx Corp., of Norcross, Ga., has appointed Richard Shulerpresident and CEO of its VetLife Inc. subsidiary.y Cygnus Therapeutic Systems, of Redwood City, Calif., has appointedNeil Ackerman vice president, research and development.y IMRE Corp., of Seattle, has named Franco Quagliata senior vicepresident and chief medical officer, and Joseph Balint vice president,research and development.y Sanguine Corp., of Pasadena, Calif., has appointed John Stavich vicepresident and technical director in charge of production.y Cohesive Biotechnologies Inc., of Acton, Mass., has appointedHubert Quinn president and CEO.

(c) 1997 American Health Consultants. All rights reserved.